Literature DB >> 10380124

Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.

V Brochez1, D Van Heuverswyn, J A Diniz, C R De Potter, E G Van den Eeckhout.   

Abstract

The determination of cellular content of octadecylphosphocholine (D-19391) and hexadecylphosphocholine (HePC, D-18506), two anticancer agents of the alkylphosphocholine group, using capillary gas chromatography is described. The compounds' cytotoxicity was first determined by the MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium] assay, being indicative for the concentration used in the uptake and retention measurements. D-19391 was added to the SK-BR-3 breast cancer cell line and HePC to the Molt-4 leukemia cell line in concentrations of, respectively, 18.6 and 15.0 microM, during a 36-h incubation period at 37 degrees C, 5% CO2. HePC uptake in the leukemia cells was followed by a 24-h reversibility test in drug-free medium. Subsequently, sample clean-up was performed on a weak cation-exchange column. For the quantitative analysis, HePC was used as internal standard for the D-19391 measurements and vice versa. Derivatization of the samples with trimethylsilylbromide was followed by capillary gas chromatographic analysis. From these data we conclude that our uptake results are quite similar with those of a previous study of HePC cellular uptake in the more resistant Caco-2T colon cancer cell line. Without having investigated the mechanism that underlies the cellular uptake results obtained, our study points to no direct correlation between the compounds' cellular uptake and their cytotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380124     DOI: 10.1007/s11745-999-0392-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  18 in total

1.  Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.

Authors:  G Powis; M J Seewald; C Gratas; D Melder; J Riebow; E J Modest
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

Review 2.  Phospholipid antitumor agents.

Authors:  W J Houlihan; M Lohmeyer; P Workman; S H Cheon
Journal:  Med Res Rev       Date:  1995-05       Impact factor: 12.944

3.  Tumor cell kinetics following antineoplastic ether phospholipid treatment.

Authors:  P Principe; C Sidoti; P Braquet
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

4.  Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.

Authors:  G W Bazill; T M Dexter
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

5.  Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells.

Authors:  E E Kelley; E J Modest; C P Burns
Journal:  Biochem Pharmacol       Date:  1993-06-22       Impact factor: 5.858

6.  Gas chromatographic determination of alkyl lysophospholipids after solid-phase extraction from cell culture media.

Authors:  J Coene; E Van den Eeckhout; P Herdewijn; P Sandra
Journal:  J Chromatogr       Date:  1993-01-29

7.  Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action.

Authors:  L Diomede; F Colotta; B Piovani; F Re; E J Modest; M Salmona
Journal:  Int J Cancer       Date:  1993-01-02       Impact factor: 7.396

8.  Investigations on the cellular uptake of hexadecylphosphocholine.

Authors:  E A Fleer; D Berkovic; H Eibl; C Unger
Journal:  Lipids       Date:  1993-08       Impact factor: 1.880

Review 9.  Hexadecylphosphocholine: preclinical and the first clinical results of a new antitumor drug.

Authors:  C Unger; H Eibl
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 10.  Membrane-interactive lipids as experimental anticancer drugs.

Authors:  W E Berdel
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more
  2 in total

1.  Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery.

Authors:  Carsten Denkert; Elmar Bucher; Mika Hilvo; Reza Salek; Matej Orešič; Julian Griffin; Scarlet Brockmöller; Frederick Klauschen; Sibylle Loibl; Dinesh Kumar Barupal; Jan Budczies; Kristiina Iljin; Valentina Nekljudova; Oliver Fiehn
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

Review 2.  Breast cancer in the era of integrating "Omics" approaches.

Authors:  Claudia Rossi; Ilaria Cicalini; Maria Concetta Cufaro; Ada Consalvo; Prabin Upadhyaya; Gianluca Sala; Ivana Antonucci; Piero Del Boccio; Liborio Stuppia; Vincenzo De Laurenzi
Journal:  Oncogenesis       Date:  2022-04-14       Impact factor: 6.524

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.